Frequently Asked Questions

Print
Published on Sunday, 09 June 2013

Frequently Asked Questions

 

These FAQs are designed to provide a better understanding of Di Bella's Method, medicines/drugs used and other technical details. They provide basic information, sometimes about fairly complex topics.

 


 

QUESTION: Why does MDB also use the anticancer chemiotherapy drug Ciclofosfamide (Endoxan), even if, according to MdB principles should damage the tissues and healthy cells of the body? Note: Cyclophosphamide: trade names Endoxan.

ANSWER: Cyclophosphamide (Endoxan), whose spectrum cover all high proliferation cells, is used at MdB with 100-200 times lower dosage vs the one used in "classical" cancer therapy.

The very low dosage, the low blood half-life time (the time in which the molecule concentration halves the drug concentration in blood) and the combined use of high dosage trophic- protection substances (vitamins, retinoids, melatonin, extracellular, matrix components, etc.) cause minimal and transient side effects.

In short, the "secret" of cyclophosphamide usage in MdB lies in its very low dosage. In that case this drug is not directly cytotoxic (=toxic to cell), but only has a "weakening" action on the neoplastic cell, hence almost not touching the healthy cells of the organism. This "weakening" promotes the cancer cell 'apoptosi' (i.e. its self-destruction).

Summing up, Professor Di Bella stated that the very low cyclophosphamide dose does not have a cytotoxic, but apoptosic action on the tumor cell, and has only negligible effects on the healthy ones.

 


 

QUESTION: GH (Growth Hormon) inhibits growth of cancer cells. But how does it effect on the growth of the other "normal" healthily cells?

ANSWER: The receptors of GH are overmarked in cancer cells: this is in fact one of multiple reasons of its "crazy" growth (the neoplastic cells grow 4 time faster than the healthy ones), i.e.:

According to some biochemistry laws (Constant Dissociation - Kd - ) GH will act on the larger receptor distribution, i.e., on the cancer cells.

Therefore to block the factors of cell growth is not that crazy, and it does not harm the healthily tissues.

This is not the case for the monoclonal antibodies, who indiscriminately block the growth, thus causing serious collateral effects.

 


 

 

Transcripted by: M.D. Carlo Z.